Journal
CANADIAN JOURNAL OF MICROBIOLOGY
Volume 61, Issue 1, Pages 60-64Publisher
CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/cjm-2014-0501
Keywords
exotoxin A - flagellin; Pseudomonas aeruginosa; vaccine candidate; fusion protein
Categories
Funding
- Research Center of Infectious and Tropical Diseases, Tabriz University of Medical Sciences, Tabriz, Iran
Ask authors/readers for more resources
Pseudomonas aeruginosa is an opportunistic bacterium that causes serious nosocomial infection in immunocompromised patients. The aim of this study was to prepare a fusion protein consisting of exotoxin A (ExoA) and flagellin (Fla) from P. aeruginosa and to evaluate its potential as a vaccine candidate against P. aeruginosa infection. The genes encoding for ExoA and Fla proteins were cloned in-frame and expressed in Escherichia coli. The recombinant ExoA-Fla fusion protein was purified by Ni-NTA affinity chromatography. Mice were immunized subcutaneously with ExoA, Fla, and ExoA-Fla fusion proteins, and the humoral immune response was evaluated by ELISA method. The immunized and control group mice were challenged with a 2x LD50 (7.5 x 10(7) CFU) of P. aeruginosa for the protection assay. The results indicated that vaccination with Fla, ExoA, and ExoA-Fla fusion proteins produced a significant amount of specific immunoglobulin G antibodies. Immunization of mice with ExoA-Fla fusion protein showed significant protection against intraperitoneal challenge with 7.5 x 10(7) CFU (2x LD50) P. aeruginosa. Results of this study suggest that recombinant ExoA-Fla fusion protein is a highly immunogenic protective protein showing promise as a vaccine candidate against P. aeruginosa.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available